Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Feb 12, 2024 (filed on Feb 14, 2024)Insider Name:Caldwell Phyllis ROwnership Type:Direct OwnershipSecurities:Common Stock, par value $0.01 per shareNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:2,000Price:$20.07
-
Mar 09, 2023 (filed on Apr 12, 2023)Insider Name:Pak AshleyOwnership Type:Direct OwnershipSecurities:Common Stock, par value $0.01 per shareNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:1,000Price:$19.41
Filings by filing date
-
Feb 12, 2024 (filed on Feb 14, 2024)Insider Name:Caldwell Phyllis ROwnership Type:Direct OwnershipSecurities:Common Stock, par value $0.01 per shareNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:2,000Price:$20.07
-
Mar 09, 2023 (filed on Apr 12, 2023)Insider Name:Pak AshleyOwnership Type:Direct OwnershipSecurities:Common Stock, par value $0.01 per shareNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:1,000Price:$19.41
News
Biz Brief
Sector: Financials | Industry: Closed End Funds |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 333 S Grand Ave Fl 28 LOS ANGELES CA 90071-1504 |
Tel: | 61-212-2841900 |
Website: | https://www.oaktreespecialtylending.com |
IR: | See website |
Key People | ||
John B. Frank Chairman of the Board | Mathew M. Pendo President | Armen Panossian Chief Executive Officer, Chief Investment Officer |
Christopher J. McKown Chief Financial Officer, Treasurer | Matthew Stewart Chief Operating Officer | Ashley Pak Chief Compliance Officer |
Business Overview |
Oaktree Specialty Lending Corporation is a specialty finance company. The Company provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Its portfolio of investments includes application software, multi-sector holdings, data processing and outsourced services, pharmaceuticals, biotechnology, health care services, specialized finance, personal products, and more. The Company is externally managed by Oaktree Fund Advisors, LLC (Oaktree). |
Financial Overview |
For the three months ended 31 December 2023, Oaktree Specialty Lending Corp revenues increased 24% to $98M. Net income decreased 20% to $10.5M. Revenues reflect Interest income Non-control/Non-affiliat increase of 29% to $82.7M, Interest on cash and cash equivalents increase from $472K to $2.4M, Control investments- interest Income increase of 31% to $6M. Net income was offset by Interest expense increase of 55% to $32.2M (expense). |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $3,063M as of Dec 31, 2023 |
Annual revenue (TTM): | $398.09M as of Dec 31, 2023 |
EBITDA (TTM): | $309.17M as of Dec 31, 2023 |
Net annual income (TTM): | $114.69M as of Dec 31, 2023 |
Free cash flow (TTM): | $169.52M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $1,510M as of Dec 31, 2023 |
Shares outstanding: | 78,965,350 as of Jan 30, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |